HK142093A - Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it - Google Patents

Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it Download PDF

Info

Publication number
HK142093A
HK142093A HK1420/93A HK142093A HK142093A HK 142093 A HK142093 A HK 142093A HK 1420/93 A HK1420/93 A HK 1420/93A HK 142093 A HK142093 A HK 142093A HK 142093 A HK142093 A HK 142093A
Authority
HK
Hong Kong
Prior art keywords
preparation
piperazinecarboxylic acid
pharmaceutical compositions
compositions containing
disorders
Prior art date
Application number
HK1420/93A
Other languages
English (en)
Inventor
Aebischer Bernhard
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK142093A publication Critical patent/HK142093A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK1420/93A 1987-02-18 1993-12-30 Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it HK142093A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878703749A GB8703749D0 (en) 1987-02-18 1987-02-18 Piperazinecarboxylic acid

Publications (1)

Publication Number Publication Date
HK142093A true HK142093A (en) 1994-01-07

Family

ID=10612501

Family Applications (1)

Application Number Title Priority Date Filing Date
HK1420/93A HK142093A (en) 1987-02-18 1993-12-30 Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it

Country Status (28)

Country Link
JP (1) JPH0723387B2 (enrdf_load_stackoverflow)
KR (1) KR960015190B1 (enrdf_load_stackoverflow)
AT (1) AT391320B (enrdf_load_stackoverflow)
AU (1) AU613009B2 (enrdf_load_stackoverflow)
BE (1) BE1002427A3 (enrdf_load_stackoverflow)
CA (1) CA1327799C (enrdf_load_stackoverflow)
CH (1) CH675125A5 (enrdf_load_stackoverflow)
CY (1) CY1739A (enrdf_load_stackoverflow)
DE (1) DE3804936C2 (enrdf_load_stackoverflow)
DK (1) DK168441B1 (enrdf_load_stackoverflow)
ES (2) ES2011319A6 (enrdf_load_stackoverflow)
FI (1) FI86733C (enrdf_load_stackoverflow)
FR (1) FR2610932B1 (enrdf_load_stackoverflow)
GB (2) GB8703749D0 (enrdf_load_stackoverflow)
GR (1) GR1002471B (enrdf_load_stackoverflow)
HK (1) HK142093A (enrdf_load_stackoverflow)
HU (2) HU199858B (enrdf_load_stackoverflow)
IE (1) IE59098B1 (enrdf_load_stackoverflow)
IL (1) IL85436A0 (enrdf_load_stackoverflow)
IT (1) IT1219447B (enrdf_load_stackoverflow)
LU (1) LU87129A1 (enrdf_load_stackoverflow)
MY (1) MY103206A (enrdf_load_stackoverflow)
NL (1) NL8800412A (enrdf_load_stackoverflow)
NZ (1) NZ223529A (enrdf_load_stackoverflow)
PH (1) PH25512A (enrdf_load_stackoverflow)
PT (1) PT86776B (enrdf_load_stackoverflow)
SE (1) SE467256B (enrdf_load_stackoverflow)
ZA (1) ZA881146B (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202111B (en) * 1988-03-11 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
US5086072A (en) * 1990-06-18 1992-02-04 The United States Of America As Represented By The Department Of Health And Human Services Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
EP0488959A3 (en) * 1990-11-28 1992-08-05 Sandoz Ltd. New uses of competitive nmda receptor antagonists
US5260286A (en) * 1992-10-16 1993-11-09 Japan Tobacco, Inc. 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists
EP0826032A1 (de) * 1995-05-08 1998-03-04 Lonza Ag Biotechnologisches verfahren zur herstellung von r-alpha-piperazincarbonsäure und s-alpha-piperazincarbonsäureamid
IL132836A0 (en) 1997-05-12 2001-03-19 Ortho Mcneil Pharm Inc Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
JP2008124531A (ja) 2006-11-08 2008-05-29 Nec Electronics Corp 半導体装置およびオーディオプロセッサチップ
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids

Also Published As

Publication number Publication date
GR880100084A (el) 1988-12-16
PT86776B (pt) 1992-05-29
GR1002471B (el) 1996-11-15
HU199858B (en) 1990-03-28
SE8800541D0 (sv) 1988-02-17
FI880744A0 (fi) 1988-02-17
CY1739A (en) 1995-10-20
ES2021904A6 (es) 1991-11-16
FI86733C (fi) 1992-10-12
IE59098B1 (en) 1994-01-12
FI880744L (fi) 1988-08-19
PT86776A (pt) 1988-03-01
MY103206A (en) 1993-05-29
IE880413L (en) 1988-08-18
IL85436A (enrdf_load_stackoverflow) 1992-12-01
JPH0723387B2 (ja) 1995-03-15
AT391320B (de) 1990-09-25
GB8803438D0 (en) 1988-03-16
GB2201676B (en) 1991-01-02
CA1327799C (en) 1994-03-15
FR2610932B1 (fr) 1990-11-16
HU211269A9 (en) 1995-11-28
DE3804936C2 (de) 1997-02-13
ZA881146B (en) 1989-10-25
AU613009B2 (en) 1991-07-25
PH25512A (en) 1991-07-24
KR880009944A (ko) 1988-10-06
NZ223529A (en) 1991-02-26
IT1219447B (it) 1990-05-18
FI86733B (fi) 1992-06-30
JPS63203691A (ja) 1988-08-23
DK168441B1 (da) 1994-03-28
BE1002427A3 (fr) 1991-02-05
SE467256B (sv) 1992-06-22
IL85436A0 (en) 1988-07-31
KR960015190B1 (ko) 1996-11-01
LU87129A1 (fr) 1988-09-20
CH675125A5 (enrdf_load_stackoverflow) 1990-08-31
AU1175888A (en) 1988-08-25
DK79688D0 (da) 1988-02-16
ATA36788A (de) 1990-03-15
DE3804936A1 (de) 1988-09-01
NL8800412A (nl) 1988-09-16
GB8703749D0 (en) 1987-03-25
IT8847631A0 (it) 1988-02-12
ES2011319A6 (es) 1990-01-01
FR2610932A1 (fr) 1988-08-19
HUT49361A (en) 1989-09-28
GB2201676A (en) 1988-09-07
DK79688A (da) 1988-08-19

Similar Documents

Publication Publication Date Title
GB2208476B (en) Improvements in or relating to apparatus for use in the treatment of spinal disorders
GB2207055B (en) Apparatus for use in the treatment of spinal disorders
SI0751129T1 (en) Substituted dihydrodibenzo(b,f)azepines, method for their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them
KR100521829B1 (en) Compositions and Methods for the Treatment of Alzheimer's Disease, Central Nervous System Injury, and Inflammatory Diseases
HUP0100786A3 (en) Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
EP0651639A4 (en) METHODS OF USING CISAPRIDE (+) FOR THE TREATMENT OF GASTROSOPHAGIC REFLUX AND OTHER DISORDERS.
IL153236A0 (en) The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
HK142093A (en) Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
AU642428B2 (en) Method of treatment of CNS disorders and /or pain using gamma aminobutyric acid autoreceptor antagonists
EP0383171A3 (en) 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
HUP0301578A3 (en) Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
IL85963A0 (en) Pharmaceutical compositions for the prophylaxis or treatment of disorders or diseases of the gastrointestinal tract,comprising antigenic substances
WO2002005801A3 (en) Compositions containing diacyltartaric salts of (e)-metanicotine
EP0273310A3 (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
WO1999020291A3 (en) Pharmaceutical grade ginkgo biloba
EP0219912A3 (en) The use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
AU608865B2 (en) Treatment of cerebral disorders
HK2794A (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
ZA859695B (en) 2-(arylalkyloxymethyl)morpholine,preparation thereof and their application as drugs which are useful in the treatment of disorders of the central nervous system
WO1999021005A3 (en) Pharmaceutical grade st. john's wort
CA2239423A1 (en) Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
CA2239433A1 (en) Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders
EP1517912A4 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISEASES USING GENES 577, 20739 OR 57145
ZA937604B (en) 3,3-disubstituted tri and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)